nodes	percent_of_prediction	percent_of_DWPC	metapath
Remoxipride—CYP2D6—Lomustine—hematologic cancer	0.155	0.189	CbGbCtD
Remoxipride—CYP2D6—Idarubicin—hematologic cancer	0.138	0.168	CbGbCtD
Remoxipride—CYP2D6—Hydroxyurea—hematologic cancer	0.118	0.143	CbGbCtD
Remoxipride—CYP2D6—Bortezomib—hematologic cancer	0.102	0.124	CbGbCtD
Remoxipride—CYP2D6—Imatinib—hematologic cancer	0.0749	0.0912	CbGbCtD
Remoxipride—CYP2D6—Nilotinib—hematologic cancer	0.0681	0.0829	CbGbCtD
Remoxipride—CYP2D6—Vinorelbine—hematologic cancer	0.0675	0.0822	CbGbCtD
Remoxipride—CYP2D6—Vinblastine—hematologic cancer	0.0416	0.0506	CbGbCtD
Remoxipride—CYP2D6—Dexamethasone—hematologic cancer	0.0308	0.0375	CbGbCtD
Remoxipride—CYP2D6—Doxorubicin—hematologic cancer	0.0256	0.0311	CbGbCtD
Remoxipride—Sulpiride—CA9—hematologic cancer	0.00821	1	CrCbGaD
Remoxipride—HTR2A—Signaling Pathways—CD86—hematologic cancer	2.79e-05	0.000164	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—NFKBIA—hematologic cancer	2.79e-05	0.000164	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—BAD—hematologic cancer	2.79e-05	0.000164	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NCOR1—hematologic cancer	2.78e-05	0.000164	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—JAK2—hematologic cancer	2.78e-05	0.000163	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—NOTCH1—hematologic cancer	2.76e-05	0.000162	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—HES1—hematologic cancer	2.75e-05	0.000162	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CSF2—hematologic cancer	2.75e-05	0.000162	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—FGF1—hematologic cancer	2.75e-05	0.000162	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NCOR1—hematologic cancer	2.74e-05	0.000161	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—FOXO1—hematologic cancer	2.71e-05	0.000159	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—IL2—hematologic cancer	2.71e-05	0.000159	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CSF2—hematologic cancer	2.71e-05	0.000159	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—FGF1—hematologic cancer	2.71e-05	0.000159	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PDGFRB—hematologic cancer	2.71e-05	0.000159	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CD80—hematologic cancer	2.71e-05	0.000159	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PIK3CG—hematologic cancer	2.7e-05	0.000159	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—KIT—hematologic cancer	2.7e-05	0.000159	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—NRAS—hematologic cancer	2.7e-05	0.000159	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MAP2K1—hematologic cancer	2.69e-05	0.000158	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—PIK3CB—hematologic cancer	2.68e-05	0.000158	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PIK3CD—hematologic cancer	2.67e-05	0.000157	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—FOXO1—hematologic cancer	2.67e-05	0.000157	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—IL2—hematologic cancer	2.67e-05	0.000157	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PDGFRA—hematologic cancer	2.67e-05	0.000157	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PDGFRB—hematologic cancer	2.66e-05	0.000157	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PRKCG—hematologic cancer	2.66e-05	0.000156	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—JAK1—hematologic cancer	2.66e-05	0.000156	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PTPN11—hematologic cancer	2.65e-05	0.000156	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—PIK3CA—hematologic cancer	2.65e-05	0.000156	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—PIK3CB—hematologic cancer	2.64e-05	0.000155	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PDGFRA—hematologic cancer	2.62e-05	0.000154	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—KRAS—hematologic cancer	2.62e-05	0.000154	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—JAK1—hematologic cancer	2.61e-05	0.000154	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PRKCG—hematologic cancer	2.61e-05	0.000154	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—MAPK3—hematologic cancer	2.59e-05	0.000152	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CREB1—hematologic cancer	2.57e-05	0.000151	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—FGF2—hematologic cancer	2.56e-05	0.00015	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—BRAF—hematologic cancer	2.54e-05	0.000149	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—NQO1—hematologic cancer	2.53e-05	0.000149	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CD44—hematologic cancer	2.53e-05	0.000149	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PIK3R1—hematologic cancer	2.52e-05	0.000148	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCL2—hematologic cancer	2.52e-05	0.000148	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL6R—hematologic cancer	2.51e-05	0.000147	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CREBBP—hematologic cancer	2.5e-05	0.000147	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL2RA—hematologic cancer	2.48e-05	0.000146	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL2—hematologic cancer	2.46e-05	0.000145	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—JAK2—hematologic cancer	2.45e-05	0.000144	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TERT—hematologic cancer	2.45e-05	0.000144	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL2RA—hematologic cancer	2.44e-05	0.000144	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL2—hematologic cancer	2.42e-05	0.000142	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TERT—hematologic cancer	2.41e-05	0.000142	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—PIK3CA—hematologic cancer	2.4e-05	0.000141	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYCS—hematologic cancer	2.4e-05	0.000141	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MDM2—hematologic cancer	2.39e-05	0.000141	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PDGFB—hematologic cancer	2.39e-05	0.000141	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MAP2K1—hematologic cancer	2.39e-05	0.000141	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	2.38e-05	0.00014	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PIK3CD—hematologic cancer	2.37e-05	0.00014	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PDGFB—hematologic cancer	2.36e-05	0.000139	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—PIK3CA—hematologic cancer	2.35e-05	0.000138	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TSC2—hematologic cancer	2.34e-05	0.000138	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MTOR—hematologic cancer	2.33e-05	0.000137	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PIK3CB—hematologic cancer	2.33e-05	0.000137	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—KRAS—hematologic cancer	2.32e-05	0.000137	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TSC2—hematologic cancer	2.3e-05	0.000135	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—FGF2—hematologic cancer	2.27e-05	0.000134	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—FGFR3—hematologic cancer	2.25e-05	0.000132	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PIK3R1—hematologic cancer	2.24e-05	0.000132	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MAPK14—hematologic cancer	2.23e-05	0.000131	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—HRAS—hematologic cancer	2.22e-05	0.000131	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—FGFR3—hematologic cancer	2.21e-05	0.00013	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MAPK14—hematologic cancer	2.19e-05	0.000129	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CDKN1B—hematologic cancer	2.19e-05	0.000129	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ESR1—hematologic cancer	2.19e-05	0.000129	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—JAK2—hematologic cancer	2.18e-05	0.000128	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—AKT1—hematologic cancer	2.16e-05	0.000127	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—FN1—hematologic cancer	2.16e-05	0.000127	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ESR1—hematologic cancer	2.15e-05	0.000126	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CASP3—hematologic cancer	2.14e-05	0.000126	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL2—hematologic cancer	2.14e-05	0.000126	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—PIK3CA—hematologic cancer	2.14e-05	0.000126	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—BAD—hematologic cancer	2.13e-05	0.000125	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NFKBIA—hematologic cancer	2.13e-05	0.000125	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—IL6—hematologic cancer	2.13e-05	0.000125	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MDM2—hematologic cancer	2.13e-05	0.000125	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—FN1—hematologic cancer	2.12e-05	0.000125	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NOTCH1—hematologic cancer	2.11e-05	0.000124	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.11e-05	0.000124	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NFKBIA—hematologic cancer	2.1e-05	0.000123	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—BAD—hematologic cancer	2.1e-05	0.000123	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCND1—hematologic cancer	2.09e-05	0.000123	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—JUN—hematologic cancer	2.08e-05	0.000122	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NOTCH1—hematologic cancer	2.08e-05	0.000122	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CD80—hematologic cancer	2.07e-05	0.000122	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MTOR—hematologic cancer	2.07e-05	0.000122	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PIK3CB—hematologic cancer	2.07e-05	0.000122	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—KIT—hematologic cancer	2.07e-05	0.000122	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PIK3CG—hematologic cancer	2.07e-05	0.000122	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—NRAS—hematologic cancer	2.07e-05	0.000122	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CD80—hematologic cancer	2.04e-05	0.00012	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PIK3CG—hematologic cancer	2.03e-05	0.00012	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—KIT—hematologic cancer	2.03e-05	0.00012	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—NRAS—hematologic cancer	2.03e-05	0.00012	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PTPN11—hematologic cancer	2.03e-05	0.000119	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CDKN1A—hematologic cancer	2.02e-05	0.000119	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PTEN—hematologic cancer	2.01e-05	0.000118	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ABCB1—hematologic cancer	2e-05	0.000118	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PTPN11—hematologic cancer	2e-05	0.000117	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—MAPK3—hematologic cancer	1.98e-05	0.000116	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—HRAS—hematologic cancer	1.98e-05	0.000116	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MAPK8—hematologic cancer	1.97e-05	0.000116	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CREB1—hematologic cancer	1.97e-05	0.000116	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—AKT1—hematologic cancer	1.96e-05	0.000115	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—MAPK3—hematologic cancer	1.95e-05	0.000114	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—BRAF—hematologic cancer	1.94e-05	0.000114	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CDKN1B—hematologic cancer	1.94e-05	0.000114	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—NCOR1—hematologic cancer	1.94e-05	0.000114	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GSTM1—hematologic cancer	1.94e-05	0.000114	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CREB1—hematologic cancer	1.94e-05	0.000114	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCL2—hematologic cancer	1.92e-05	0.000113	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—AKT1—hematologic cancer	1.92e-05	0.000113	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—EP300—hematologic cancer	1.92e-05	0.000113	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL6R—hematologic cancer	1.92e-05	0.000113	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CREBBP—hematologic cancer	1.92e-05	0.000113	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—BRAF—hematologic cancer	1.91e-05	0.000112	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CASP3—hematologic cancer	1.9e-05	0.000112	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL2—hematologic cancer	1.9e-05	0.000112	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCL2—hematologic cancer	1.89e-05	0.000111	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—IL6—hematologic cancer	1.89e-05	0.000111	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL6R—hematologic cancer	1.89e-05	0.000111	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CREBBP—hematologic cancer	1.89e-05	0.000111	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—SRC—hematologic cancer	1.87e-05	0.00011	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCND1—hematologic cancer	1.85e-05	0.000109	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—JUN—hematologic cancer	1.85e-05	0.000109	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MAP2K1—hematologic cancer	1.83e-05	0.000108	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—VEGFA—hematologic cancer	1.82e-05	0.000107	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PIK3CD—hematologic cancer	1.82e-05	0.000107	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—STAT3—hematologic cancer	1.8e-05	0.000106	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.8e-05	0.000106	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MAP2K1—hematologic cancer	1.8e-05	0.000106	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—NRAS—hematologic cancer	1.8e-05	0.000106	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CDKN1A—hematologic cancer	1.79e-05	0.000105	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PTEN—hematologic cancer	1.79e-05	0.000105	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PIK3CD—hematologic cancer	1.79e-05	0.000105	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—KRAS—hematologic cancer	1.78e-05	0.000105	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—PIK3CA—hematologic cancer	1.77e-05	0.000104	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—KRAS—hematologic cancer	1.75e-05	0.000103	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MAPK8—hematologic cancer	1.75e-05	0.000103	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—AKT1—hematologic cancer	1.74e-05	0.000103	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—FGF2—hematologic cancer	1.74e-05	0.000102	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MAPK3—hematologic cancer	1.72e-05	0.000101	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.72e-05	0.000101	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PIK3R1—hematologic cancer	1.72e-05	0.000101	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—FGF2—hematologic cancer	1.71e-05	0.000101	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—EP300—hematologic cancer	1.71e-05	0.0001	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PIK3R1—hematologic cancer	1.69e-05	9.92e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MYC—hematologic cancer	1.67e-05	9.84e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—TGFB1—hematologic cancer	1.67e-05	9.81e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—JAK2—hematologic cancer	1.67e-05	9.8e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—SRC—hematologic cancer	1.66e-05	9.75e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—JAK2—hematologic cancer	1.64e-05	9.65e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—PIK3CA—hematologic cancer	1.63e-05	9.61e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MDM2—hematologic cancer	1.63e-05	9.57e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—VEGFA—hematologic cancer	1.62e-05	9.5e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—PIK3CA—hematologic cancer	1.61e-05	9.45e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MDM2—hematologic cancer	1.6e-05	9.42e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—STAT3—hematologic cancer	1.6e-05	9.4e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—NRAS—hematologic cancer	1.6e-05	9.38e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PIK3CB—hematologic cancer	1.58e-05	9.31e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MTOR—hematologic cancer	1.58e-05	9.31e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MTOR—hematologic cancer	1.56e-05	9.16e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PIK3CB—hematologic cancer	1.56e-05	9.16e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—KRAS—hematologic cancer	1.55e-05	9.09e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MAPK3—hematologic cancer	1.53e-05	8.98e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—HRAS—hematologic cancer	1.51e-05	8.89e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—HRAS—hematologic cancer	1.49e-05	8.75e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CDKN1B—hematologic cancer	1.49e-05	8.74e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MYC—hematologic cancer	1.49e-05	8.74e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—TGFB1—hematologic cancer	1.48e-05	8.72e-05	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—AKT1—hematologic cancer	1.47e-05	8.64e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CDKN1B—hematologic cancer	1.46e-05	8.6e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CASP3—hematologic cancer	1.46e-05	8.56e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL2—hematologic cancer	1.45e-05	8.55e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL6—hematologic cancer	1.45e-05	8.51e-05	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—AKT1—hematologic cancer	1.45e-05	8.5e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.44e-05	8.48e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CASP3—hematologic cancer	1.43e-05	8.43e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL2—hematologic cancer	1.43e-05	8.41e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL6—hematologic cancer	1.42e-05	8.37e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PIK3CA—hematologic cancer	1.42e-05	8.35e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCND1—hematologic cancer	1.42e-05	8.34e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—JUN—hematologic cancer	1.41e-05	8.32e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCND1—hematologic cancer	1.39e-05	8.2e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—JUN—hematologic cancer	1.39e-05	8.18e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—TP53—hematologic cancer	1.37e-05	8.08e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—KRAS—hematologic cancer	1.37e-05	8.07e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	1.37e-05	8.06e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PTEN—hematologic cancer	1.37e-05	8.05e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CDKN1A—hematologic cancer	1.35e-05	7.93e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PTEN—hematologic cancer	1.35e-05	7.92e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MAPK8—hematologic cancer	1.34e-05	7.87e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.34e-05	7.86e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—AKT1—hematologic cancer	1.33e-05	7.85e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MAPK8—hematologic cancer	1.32e-05	7.74e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—HRAS—hematologic cancer	1.31e-05	7.73e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—AKT1—hematologic cancer	1.31e-05	7.72e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—EP300—hematologic cancer	1.3e-05	7.67e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—EP300—hematologic cancer	1.28e-05	7.55e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—SRC—hematologic cancer	1.27e-05	7.46e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.27e-05	7.45e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PIK3CA—hematologic cancer	1.26e-05	7.42e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL6—hematologic cancer	1.26e-05	7.39e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ALB—hematologic cancer	1.25e-05	7.36e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—SRC—hematologic cancer	1.25e-05	7.34e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—VEGFA—hematologic cancer	1.24e-05	7.27e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—STAT3—hematologic cancer	1.22e-05	7.2e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NRAS—hematologic cancer	1.22e-05	7.18e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—TP53—hematologic cancer	1.22e-05	7.18e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	1.22e-05	7.15e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—STAT3—hematologic cancer	1.2e-05	7.08e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NRAS—hematologic cancer	1.2e-05	7.06e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.2e-05	7.04e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MAPK3—hematologic cancer	1.17e-05	6.87e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—HRAS—hematologic cancer	1.17e-05	6.86e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—AKT1—hematologic cancer	1.16e-05	6.82e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	1.15e-05	6.76e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MYC—hematologic cancer	1.14e-05	6.69e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TGFB1—hematologic cancer	1.13e-05	6.67e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MYC—hematologic cancer	1.12e-05	6.58e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL6—hematologic cancer	1.12e-05	6.57e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	1.12e-05	6.56e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.1e-05	6.5e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—KRAS—hematologic cancer	1.05e-05	6.18e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—KRAS—hematologic cancer	1.03e-05	6.08e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AKT1—hematologic cancer	1.03e-05	6.06e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	9.65e-06	5.68e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PTEN—hematologic cancer	9.54e-06	5.61e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	9.5e-06	5.58e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TP53—hematologic cancer	9.34e-06	5.49e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TP53—hematologic cancer	9.19e-06	5.4e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—EP300—hematologic cancer	9.1e-06	5.35e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HRAS—hematologic cancer	8.93e-06	5.25e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—HRAS—hematologic cancer	8.79e-06	5.17e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL6—hematologic cancer	8.55e-06	5.03e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL6—hematologic cancer	8.41e-06	4.95e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AKT1—hematologic cancer	7.89e-06	4.64e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AKT1—hematologic cancer	7.76e-06	4.56e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PIK3CA—hematologic cancer	6.73e-06	3.96e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—AKT1—hematologic cancer	5.5e-06	3.23e-05	CbGpPWpGaD
